Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$628,461
-$33,048 QoQ
Shares Held
10,907
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,405
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Nebraska Trust Co holds $45,421,134 across 9 Drug Manufacturers - General names. BMY ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,346 | $17,103,863 | |
| 2 | MRK |
Merck & Co., Inc.
|
104,140 | $13,381,990 | |
| 3 | LLY |
ELI LILLY & Co
|
6,923 | $8,303,654 | |
| 4 | PFE |
Pfizer Inc
|
106,986 | $2,576,222 | |
| 5 | ABBV |
AbbVie Inc.
|
7,172 | $1,804,762 | |
| 6 | AMGN |
Amgen Inc
|
2,369 | $857,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
10,907 | $628,461 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,802 | $480,344 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $628,461 | 10,907 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $661,509 | 10,907 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $599,111 | 11,107 | Shares | Sole | 2026-06-02 | |
| 2025-09-30 | $502,414 | 11,140 | Shares | Sole | 2026-06-09 | |
| 2025-06-30 | $515,670 | 11,140 | Shares | Sole | 2026-06-10 | |
| 2025-03-31 | $679,428 | 11,140 | Shares | Sole | 2026-06-10 | |
| 2024-12-31 | $621,594 | 10,990 | Shares | Sole | 2026-06-12 | |
| 2024-09-30 | $568,622 | 10,990 | Shares | Sole | 2026-06-12 | |
| 2024-06-30 | $467,960 | 11,268 | Shares | Sole | 2026-06-15 | |
| 2024-03-31 | $611,063 | 11,268 | Shares | Sole | 2026-06-16 | |
| 2023-12-31 | $578,161 | 11,268 | Shares | Sole | 2026-06-16 | |
| 2023-09-30 | $653,994 | 11,268 | Shares | Sole | 2026-06-16 | |
| 2023-06-30 | $717,327 | 11,217 | Shares | Sole | 2026-06-17 | |
| 2023-03-31 | $763,588 | 11,017 | Shares | Sole | 2026-06-17 | |
| 2022-12-31 | $792,673 | 11,017 | Shares | Sole | 2026-06-22 | |
| 2022-09-30 | $783,198 | 11,017 | Shares | Sole | 2026-06-22 | |
| 2022-06-30 | $830,368 | 10,784 | Shares | Sole | 2026-06-23 | |
| 2022-03-31 | $787,555 | 10,784 | Shares | Sole | 2026-06-23 | |
| 2021-12-31 | $672,382 | 10,784 | Shares | Sole | 2026-06-24 | |
| 2021-09-30 | $642,882 | 10,865 | Shares | Sole | 2026-06-25 | |
| 2021-06-30 | $705,953 | 10,565 | Shares | Sole | 2026-06-26 | |
| 2021-03-31 | $666,968 | 10,565 | Shares | Sole | 2026-06-26 | |
| 2020-12-31 | $643,623 | 10,376 | Shares | Sole | 2026-06-29 | |
| 2020-09-30 | $565,279 | 9,376 | Shares | Sole | 2026-06-29 | |
| 2020-06-30 | $1,023,178 | 17,401 | Shares | Sole | 2026-07-01 | |
| 2020-03-31 | $1,141,499 | 20,479 | Shares | Sole | 2026-07-01 | |
| No filing history on record for this holder in this stock. | ||||||